Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Simon · SciRah

Researcher profile · Semantic Scholar

K. Simon

Share profile

K. Simon — researcher profile on SciRah

h-index: 16
Works: 69
Citations: 1,215

Most-cited papers

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study.
T. Berg, K. Simon, S. Mauss, E. Schott +14 more
2017Journal of Hepatology269 citations
Semantic Scholar
Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01).
P. Ingiliz, S. Christensen, Torben Kimhofer, D. Hueppe +12 more
2016Clinical Infectious Diseases214 citations
Semantic Scholar
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B.
F. van Bömmel, K. Stein, R. Heyne, J. Petersen +25 more
2023Journal of Hepatology92 citations Open access
Semantic Scholar
Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: Current incidence rates compared with rates during the interferon era.
P. Ingiliz, M. Wehmeyer, C. Boesecke, J. Schulze zur Wiesch +8 more
2020Clinical Infectious Diseases61 citations Open access
Semantic Scholar
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection
J. von Felden, J. Vermehren, P. Ingiliz, S. Mauss +14 more
2018Alimentary Pharmacology and Therapeutics61 citations Open access
Semantic Scholar
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C.
P. Buggisch, J. Vermehren, S. Mauss, R. Günther +10 more
2017Journal of Hepatology56 citations
Semantic Scholar
Effect of Antiviral Therapy for HCV on Lipid Levels
S. Mauss, F. Berger, M. Wehmeyer, P. Ingiliz +7 more
2016Antiviral Therapy53 citations Open access
Semantic Scholar
Efficacy and tolerability of peginterferon alfa‐2a or alfa‐2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study
T. Witthoeft, D. Hueppe, C. John, J. Goelz +9 more
2010Journal of Viral Hepatitis46 citations
Semantic Scholar
Estimating the likelihood of sustained virological response in chronic hepatitis C therapy
S. Mauss, D. Hueppe, C. John, J. Goelz +11 more
2011Journal of Viral Hepatitis34 citations
Semantic Scholar
Real‐world effectiveness of sofosbuvir‐based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO‐03)
M. Wehmeyer, P. Ingiliz, S. Christensen, D. Hueppe +12 more
2018Journal of Medical Virology29 citations
Semantic Scholar
Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
J. Thiele, K. Simon, Robert Fischer, R. Zankovich
1988Pathology, Research and Practice24 citations
Semantic Scholar
Deutsches Hepatitis C-Register (DHC-R) – eine Zwischenbilanz 4 Jahre nach Zulassung direkt antiviraler Substanzen (DAAs)
D. Hüppe, Y. Serfert, P. Buggisch, S. Mauss +12 more
2019Zeitschrift für Gastroenterologie - German Journal of Gastroenterology20 citations
Semantic Scholar
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections.
J. Dietz, U. Spengler, B. Müllhaupt, J. Schulze zur Wiesch +303 more
2019Clinical Gastroenterology and Hepatology20 citations Open access
Semantic Scholar
Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C Registry
G. Dultz, Tobias Müller, J. Petersen, S. Mauss +10 more
2018Drugs & Aging19 citations
Semantic Scholar
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen.
Adolfo de Salazar, J. Dietz, V. D. di Maio, J. Vermehren +85 more
2020Journal of Antimicrobial Chemotherapy17 citations Open access
Semantic Scholar
Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)
B. Schlevogt, K. Boeker, S. Mauss, H. Klinker +7 more
2021Biomedicines16 citations Open access
Semantic Scholar
840 EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2a OR -2b PLUS RIBAVIRIN IN THE ROUTINE DAILY TREATMENT OF CHRONIC HEPATITIS C PATIENTS IN GERMANY: THE PRACTICE STUDY
T. Witthoeft, D. Hueppe, C. John, J. Goelz +14 more
200816 citations
Semantic Scholar
The use of the anti-factor VIII method on trephine biopsies of the bone marrow for the identification of immature and atypical megakaryocytes in myeloproliferative diseases and allied disorders
J. Thiele, R. Krech, S. Wienhold, K. Simon +2 more
1987Virchows Archiv B Cell Pathology Including Molecular Pathology14 citations
Semantic Scholar
Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral treatment
V. Knop, W. Hofmann, P. Buggisch, H. Klinker +9 more
2018Journal of Viral Hepatitis13 citations
Semantic Scholar
Has Increased Rollout of Direct Acting Antiviral Therapy Decreased the Burden of Late Presentation and Advanced Liver Disease in Patients Starting Hepatitis C Virus Therapy in Germany?
J. Bischoff, C. Boesecke, P. Ingiliz, F. Berger +9 more
2020Journal of Clinical Gastroenterology12 citations
Semantic Scholar
O119 : Stopping tenofovir disoproxil fumarate (TDF) treatment after long term virologic suppression in HBeAg-negative CHB: Week 48 interim results from an ongoing randomized, controlled trial (“finite CHB”)
T. Berg, K. Simon, S. Mauss, E. Schott +12 more
201512 citations
Semantic Scholar
Stopping Tenofovir Disoproxil Fumarate (TDF) treatment after long term virologic suppression in HBeAg-negative CHB: Week 48 interim results from an ongoing randomized, controlled trial („FINITE CHB“)
T. Berg, K. Simon, S. Mauss, E. Schott +12 more
201512 citations
Semantic Scholar
Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R)
J. Vermehren, Y. Serfert, M. Cornberg, A. Stoehr +10 more
2020Zeitschrift für Gastroenterologie - German Journal of Gastroenterology10 citations
Semantic Scholar
Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R)
M. Cornberg, A. Stoehr, U. Naumann, G. Teuber +6 more
2022Viruses9 citations Open access
Semantic Scholar
Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy – data from the German hepatitis C registry (DHC-R)
A. Schmitt, R. Günther, S. Mauss, K. Boeker +11 more
2020Zeitschrift für Gastroenterologie - German Journal of Gastroenterology9 citations
Semantic Scholar
872 SUBSTANTIAL RENAL IMPAIRMENT IS NOT INFREQUENT IN HCV PATIENTS UNDER TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR
S. Mauss, C. Eisenbach, B. Moeller, G. Moog +11 more
20139 citations
Semantic Scholar
Risk factors for remaining liver injury in patients with virological elimination of chronic hepatitis C
S. Mauss, L. Buendgens, S. Christensen, P. Ingiliz +7 more
2019Zeitschrift für Gastroenterologie - German Journal of Gastroenterology8 citations
Semantic Scholar
P0777 : Sofosbuvir-based treatment under real life conditions in Germany (The sofger trial)
P. Buggisch, C. Sarrazin, S. Mauss, H. Hinrichsen +4 more
20158 citations
Semantic Scholar
Ledipasvir/Sofosbuvir Treatment for 8 Weeks in Treatment-Naïve HCV Genotype 1 Infected Patients under Real Life Conditions: Data from the German Hepatitis C-Registry (DHC-R)
P. Buggisch, K. Böker, R. Günther, G. Teuber +8 more
20166 citations
Semantic Scholar
[Current recommendations for the treatment of chronic hepatitis C].
C. Sarrazin, T. Berg, P. Buggisch, M. Dollinger +9 more
2014Zeitschrift für Gastroenterologie - German Journal of Gastroenterology6 citations
Semantic Scholar
THU-188-Retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C virus infection and prior DAA failure: An analysis from the German hepatitis C registry (DHC-R)
J. Vermehren, A. Stoehr, J. S. zur Wiesch, H. Klinker +8 more
2019Journal of Hepatology5 citations
Semantic Scholar
Long-term follow-up after IFN-free therapy of advanced HCV-associated liver cirrhosis: continued improvement of liver function parameters – Results from the German Hepatitis C-Registry (DHC-R)
K. Deterding, S. Mauss, A. Pathil, P. Buggisch +13 more
20175 citations
Semantic Scholar
P0835 : German multicenter cohort on sofosbuvir-based treatments in HCV mono- and HIV/HCV co-infected patients (GECOSO)
P. Ingiliz, S. Christensen, D. Hueppe, T. Lutz +7 more
20155 citations
Semantic Scholar
Relapse and Treatment-Emergent RAVS with DAA-Based Regimens in Hepatitis C Virus (HCV) Mono- or Human Immunodeficiency Virus (HIV)-HCV Co-Infected Patients – a Real Concern in Clinical Practice? Results from the German Hepatitis C Cohort (GECCO)
S. Christensen, Patrick Ingiliz, K. Schewe, J. Rockstroh +8 more
20164 citations
Semantic Scholar
Safety and Efficacy of IFN- Free Antiviral Therapies in Advanced HCV- Associated Liver Cirrhosis: Results from the German Hepatitis C-Registry (DHC-R)
K. Deterding, P. Buggisch, H. Klinker, K. Simon +11 more
20163 citations
Semantic Scholar
GS-07-Real-world safety, effectiveness, and patient-reported outcomes in patients with chronic hepatitis C virus infection treated with glecaprevir/pibrentasvir: Data from the German Hepatitis C-Registry
M. Cornberg, A. Stoehr, Naumann Uwe, H. Klinker +7 more
2019Journal of Hepatology2 citations
Semantic Scholar
Evolution of HCV patient characteristics and DAA regimens in the German Hepatitis C Registry (DHC-R) in 2014 and 2015
C. Sarrazin, P. Buggisch, S. Mauss, Tobias Müller +8 more
2019Zeitschrift für Gastroenterologie - German Journal of Gastroenterology2 citations
Semantic Scholar
Effectiveness and Safety of DAA Combination Therapies for Treatment of HCV in Elderly Patients (>70 Yrs): Results from the German Hepatitis C-Registry
T. Welzel, E. Schott, J. Petersen, S. Mauss +9 more
20162 citations
Semantic Scholar
723 Substantial Renal Impairment Is Not Infrequent in HCV Patients Under Triple Therapy With Telaprevir or Boceprevir
S. Mauss, C. Eisenbach, R. Heyne, G. Moog +9 more
20132 citations Open access
Semantic Scholar
811 ESTIMATING THE LIKELIHOOD OF SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C (CHC) THERAPY
S. Mauss, D. Hueppe, C. John, J. Goelz +14 more
20082 citations Open access
Semantic Scholar
[So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. I. Initial clinical and histologic findings in 102 patients with special reference to early hyperplastic and advanced fibrosclerotic stages].
R. Zankovich, J. Thiele, B. Mödder, T. Steinberg +3 more
1988Medizinische Klinik2 citations
Semantic Scholar
Utilization and effectiveness of elbasvir/grazoprevir and adoption of resistance-associated substitutions testing in real-world treatment of hepatitis C virus genotype 1A infection: results from the German Hepatitis C-Registry
H. Hinrichsen, A. Stoehr, M. Cornberg, H. Klinker +7 more
2020European Journal of Gastroenterology and Hepathology1 citations Open access
Semantic Scholar
THU-145-High real-world effectiveness of elbasvir/grazoprevir in a HCV genotype 1 population with a migration background and predominant subtype 1b infection: Results from the German hepatitis C registry (DHC-R)
D. Hüppe, A. Stoehr, M. Cornberg, H. Klinker +7 more
2019Journal of Hepatology1 citations
Semantic Scholar
Utilization of elbasvir/grazoprevir (EBR/GZR) and adoption of resistance associated substitutions (RAS) testing in real-world treatment of HCV genotype 1 (GT1) infection: results from the German Hepatitis C Registry (DHC-R)
H. Hinrichsen, H. Klinker, A. Stoehr, C. John +10 more
2018Zeitschrift für Gastroenterologie - German Journal of Gastroenterology1 citations
Semantic Scholar
Has increased rollout of DAA therapy decreased the burden of late presentation and advanced liver disease in patients starting HCV therapy in Germany
J. Rockstroh, C. Boesecke, P. Ingiliz, B. Florian +8 more
20181 citations
Semantic Scholar
Use of the 6 million viral load cut-off to guide treatment duration with ledipasvir/sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection: results from the German Hepatitis C-Registry (DHC-R)
J. Vermehren, C. Athmann, R. Günther, E. Schott +10 more
20171 citations
Semantic Scholar
Parameters Associated with Treatment Failure with Direct Acting Antivirals against the Hepatitis C Virus (HCV) – Results Fro the German Hepatitis C Cohort (GECCO)
Patrick Ingiliz, S. Christensen, Torben Kimhofer, D. Hueppe +6 more
20161 citations
Semantic Scholar
1149 PREDICTIVE FACTORS FOR NONRESPONSE IN GENOTYPE 2/3 INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE SETTING
J. Petersen, T. Lutz, R. Link, G. Moog +15 more
20121 citations
Semantic Scholar
[So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. II. Course and therapy in 102 patients with special reference to early hyperplastic and advanced fibrosclerotic stages].
R. Zankovich, J. Thiele, B. Mödder, T. Steinberg +3 more
1988Medizinische Klinik1 citations
Semantic Scholar
Most vulnerable HCV patient groups treated with direct acting antivirals achieve high response rates and gain quality of life-data from the German hepatitis C-registry (DHC-R)
S. Christensen, A. Stoehr, G. Teuber, J. Petersen +7 more
2023Journal of Hepatology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Mauss×33
Invite
S. Mauss — researcher profile on SciRah
D. Hueppe×18
Invite
D. Hueppe — researcher profile on SciRah
P. Buggisch×16
Invite
P. Buggisch — researcher profile on SciRah
R. Heyne×14
Invite
R. Heyne — researcher profile on SciRah

×14

Invite

M. Cornberg — researcher profile on SciRah

Invite

T. Lutz — researcher profile on SciRah

A. Baumgarten×14

Invite

A. Baumgarten — researcher profile on SciRah

C. Sarrazin×14

Invite

C. Sarrazin — researcher profile on SciRah

Invite

H. Klinker — researcher profile on SciRah

S. Christensen×13

Invite

S. Christensen — researcher profile on SciRah

H. Wedemeyer×13

Invite

H. Wedemeyer — researcher profile on SciRah

Invite

T. Berg — researcher profile on SciRah